Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vor Biopharma Inc (NQ: VOR ) 0.9163 -0.0437 (-4.55%) Streaming Delayed Price Updated: 2:28 PM EST, Nov 14, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 343,504 Open 0.9600 Bid (Size) 0.9007 (8) Ask (Size) 0.9168 (8) Prev. Close 0.9600 Today's Range 0.8800 - 0.9800 52wk Range 0.6300 - 3.140 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Vor Bio to Participate in the Stifel 2024 Healthcare Conference November 12, 2024 From Vor Biopharma Via GlobeNewswire Vor Bio Reports Third Quarter 2024 Financial Results and Provides Company Update November 07, 2024 From Vor Biopharma Via GlobeNewswire Performance YTD -58.91% -58.91% 1 Month +37.89% +37.89% 3 Month +11.07% +11.07% 6 Month -47.34% -47.34% 1 Year -52.28% -52.28% More News Read More 12 Health Care Stocks Moving In Monday's After-Market Session September 30, 2024 Via Benzinga Vor Bio Appoints Seasoned Healthcare Institutional Investor, Han Choi, M.D., LL.M., as Chief Financial Officer September 30, 2024 From Vor Biopharma Via GlobeNewswire Vor Biopharma: Q4 Earnings Insights March 20, 2024 Via Benzinga Why Oracle Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket September 10, 2024 Via Benzinga What's Going On With Penny Stock Blood Cancer-Focused Vor Biopharma On Friday? September 06, 2024 Via Benzinga Exposures Product Safety Why Argan Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket September 06, 2024 Via Benzinga New Clinical Data Validates Vor Bio’s Approach of Using Shielded Transplants to Deliver Targeted Therapies September 05, 2024 From Vor Biopharma Via GlobeNewswire Vor Bio to Participate in Upcoming Investor Conferences August 28, 2024 From Vor Biopharma Via GlobeNewswire VOR Stock Earnings: Vor Biopharma Beats EPS for Q2 2024 August 09, 2024 Via InvestorPlace Vor Bio Reports Second Quarter 2024 Financial Results and Provides Company Update August 08, 2024 From Vor Biopharma Via GlobeNewswire Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) August 02, 2024 From Vor Biopharma Via GlobeNewswire Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) July 09, 2024 From Vor Biopharma Via GlobeNewswire Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) June 04, 2024 From Vor Biopharma Via GlobeNewswire VOR Stock Earnings: Vor Biopharma Beats EPS for Q1 2024 May 09, 2024 Via InvestorPlace Vor Bio Reports First Quarter 2024 Financial Results and Provides Company Update May 09, 2024 From Vor Biopharma Via GlobeNewswire Vor Bio to Participate in Upcoming Investor Conferences May 06, 2024 From Vor Biopharma Via GlobeNewswire Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) May 03, 2024 From Vor Biopharma Via GlobeNewswire Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors May 02, 2024 From Vor Biopharma Via GlobeNewswire 12 Health Care Stocks Moving In Friday's After-Market Session April 05, 2024 Via Benzinga Vor Bio to Participate in Upcoming Investor Conferences April 01, 2024 From Vor Biopharma Via GlobeNewswire The Penny Stock A-List: 7 High-Profile Companies on the Verge of Greatness March 28, 2024 Via InvestorPlace VOR Stock Earnings: Vor Biopharma Beats EPS for Q4 2023 March 20, 2024 Via InvestorPlace Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update March 20, 2024 From Vor Biopharma Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
